![]() |
Volumn 46, Issue 12, 2005, Pages 2325-2328
|
Cardiac resynchronization devices: The Food and Drug Administration's regulatory considerations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD VESSEL GRAFT;
CARDIAC RESYNCHRONIZATION THERAPY;
DEFIBRILLATOR;
DEVICE;
FOOD AND DRUG ADMINISTRATION;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
MARKET;
PACEMAKER;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
RISK ASSESSMENT;
TREATMENT INDICATION;
VALIDATION PROCESS;
BIOMEDICAL TECHNOLOGY;
CARDIAC OUTPUT, LOW;
CLINICAL TRIALS;
DEVICE APPROVAL;
HUMANS;
PACEMAKER, ARTIFICIAL;
PRODUCT SURVEILLANCE, POSTMARKETING;
RESEARCH DESIGN;
|
EID: 28944445597
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2005.04.068 Document Type: Review |
Times cited : (7)
|
References (8)
|